Haleos Labs Limited Files Annual Confirmation for Approved Reclassification Under SEBI Regulation 31A

2 min read     Updated on 08 Apr 2026, 01:00 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Haleos Labs Limited filed annual confirmation on April 8, 2026, with stock exchanges regarding two former promoters who were reclassified to public category under SEBI Regulation 31A in April 2022. Mr. Suresh Babu Potluri and Mr. Hari Kishore Potluri, who currently hold no shares, have confirmed continued compliance with regulatory requirements including maintaining shareholding below 10% and not exercising control over company affairs.

powered bylight_fuzz_icon
37179035

*this image is generated using AI for illustrative purposes only.

Haleos Labs Limited has submitted its annual confirmation to stock exchanges regarding the continued compliance of reclassified former promoters with SEBI regulations. The company filed the confirmation on April 8, 2026, with both BSE Limited and National Stock Exchange of India Limited.

Reclassification Details

The annual confirmation relates to the reclassification application that was approved by both stock exchanges on April 13, 2022. Under this approval, two former promoters were reclassified from promoter category to public category in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Parameter Details
Filing Date April 8, 2026
Original Approval Date April 13, 2022
Regulation SEBI Regulation 31A
Reclassified Persons 2 former promoters

Former Promoters Status

The confirmation covers two individuals who were reclassified to public category:

Sr. No. Name of Erstwhile Promoters Current Shareholding % of Holding
1 Mr. Suresh Babu Potluri - -
2 Mr. Hari Kishore Potluri - -

Both former promoters currently hold no shares in the company, as indicated by the dash entries in their shareholding status.

Compliance Confirmations

Both Mr. Suresh Babu Potluri and Mr. Hari Kishore Potluri have provided individual declarations dated April 5, 2026, confirming their continued compliance with regulatory requirements. Their confirmations include several key compliance points:

  • Do not hold more than 10% of total voting rights in the company
  • Do not exercise control over company affairs, directly or indirectly
  • Do not have special rights through formal or informal arrangements
  • Are not represented on the Board of Directors
  • Do not act as key managerial persons of the company
  • Are not wilful defaulters as per RBI Guidelines
  • Are not fugitive economic offenders
  • Have no pending regulatory action against them

Regulatory Framework

The individuals must continue complying with specific sub-clauses of Regulation 31A(3) at all times from the reclassification date. Additionally, they must comply with certain conditions for a period of not less than 3 years from the date of reclassification. Failure to maintain compliance would result in their reclassification as promoters or persons belonging to the promoter group.

Company Information

Haleos Labs Limited, formerly known as SMS Lifesciences India Limited, is headquartered in Hyderabad with its registered office at Plot No. 19-III, Rod No. 71, Jubilee Hills. The company secretary Trupti Ranjan Mohanty signed the filing documents on behalf of the company.

Historical Stock Returns for Haleos

1 Day5 Days1 Month6 Months1 Year5 Years
+1.05%+2.03%+1.04%+14.10%+1.89%+130.40%

What strategic changes might Haleos Labs pursue now that former promoters have maintained zero shareholding for four years since reclassification?

How could the successful promoter reclassification impact Haleos Labs' ability to attract new institutional investors or strategic partners?

Will other pharmaceutical companies follow similar promoter reclassification strategies to improve corporate governance ratings?

Haleos Labs Limited Updates Official Contact Details Following Name Change

1 min read     Updated on 30 Mar 2026, 09:21 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Haleos Labs Limited has updated its official contact details following its name change from SMS Lifesciences India Limited. The company informed stock exchanges on March 30, 2026, about new email addresses info@haleoslabs.com and cs@haleoslabs.com, and website www.haleoslabs.com. The changes follow the company's name change approved through postal ballot on August 1, 2025, with fresh incorporation certificate received on August 21, 2025.

powered bylight_fuzz_icon
36431481

*this image is generated using AI for illustrative purposes only.

Haleos Labs Limited has officially updated its contact details following the company's name change from SMS Lifesciences India Limited. The company informed BSE Limited and National Stock Exchange of India Limited on March 30, 2026, about the updated email IDs and website address under Regulation 30 of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Updated Contact Details

The company has implemented new official contact information to align with its rebranded identity:

Contact Type: New Details
Email IDs: info@haleoslabs.com , cs@haleoslabs.com
Website: www.haleoslabs.com
Trading Symbol: HALEOSLABS

Background of Name Change

The contact detail updates are consequent to the company's name change from SMS Lifesciences India Limited to Haleos Labs Limited. This transformation received approval through postal ballot with results declared on August 1, 2025. The Ministry of Corporate Affairs subsequently issued a fresh Certificate of Incorporation on August 21, 2025.

The stock exchanges also implemented corresponding changes, with the National Stock Exchange of India Limited issuing Circular No. NSE/LIST/373 and BSE Limited issuing Notice No. 20251120-43 on November 20, 2025, incorporating the new scrip ID HALEOSLABS.

Shareholder Communication

Haleos Labs Limited dispatched communications to its physical shareholders on March 30, 2026, informing them about the updated contact details. The company emphasized that the name change does not alter its legal status in any manner, with the Corporate Identification Number and all other legal identities remaining unchanged.

Company Operations

The company clarified that there is no impact on day-to-day operations due to these changes. All official communications and disclosures have been updated to reflect the new contact information. The company continues to operate from its registered and corporate office at Plot No. 19-III, Road No. 71, Jubilee Hills, Hyderabad.

Historical Stock Returns for Haleos

1 Day5 Days1 Month6 Months1 Year5 Years
+1.05%+2.03%+1.04%+14.10%+1.89%+130.40%

What strategic business objectives or market positioning goals drove Haleos Labs' decision to rebrand from SMS Lifesciences?

Will the rebranding to Haleos Labs be accompanied by changes in the company's product portfolio or target therapeutic areas?

How might this name change impact investor perception and the company's ability to attract new partnerships in the pharmaceutical sector?

More News on Haleos

1 Year Returns:+1.89%